MYRIAD GENETICS INC

By person

44 insiders · 135 transactions

5.5×

Samraat S. Raha holds 5.5 times base salary in stock. $4.76M of shares against $856.90K in salary for 2025.

Salary from the company's own proxy. The shares are what Samraat S. Raha last reported holding, valued at $4.46, the price Common Stock was last bought or sold at on the open market here, on 8 Jun 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

LANCHBURY JERRY S

See Remarks

—

$24.83M (34) scheduled

−$24.83M

264,324

0.2763%

$1.18M

+135.3%

Capone Mark Christopher

President & C.E.O.

—

$12.73M (7) scheduled

−$12.73M

522,216

0.5460%

$2.33M

+141.0%

MARSH RICHARD M

E.V.P., General Counsel

—

$9.15M (7) scheduled

−$9.15M

144,174

0.1507%

$642.47K

+30.9%

DIAZ PAUL J

President and CEO

—

$6.47M (5)

−$6.47M

891,844

0.9324%

$3.97M

—

LANGER DENNIS

Director

—

$4.53M (10) scheduled

−$4.53M

106,802

0.1117%

$475.93K

+510.3%

Hart Jayne B.

See Remarks

—

$4.28M (7) scheduled

−$4.28M

172,561

0.1804%

$768.97K

+75.6%

King Gary A.

Exec. VP International Ops

—

$4.09M (6) scheduled

−$4.09M

148,397

0.1551%

$661.29K

+34.3%

Riggsbee Richard Bryan

Chief Financial Officer

—

$3.45M (8)

−$3.45M

291,812

0.3051%

$1.30M

+315.3%

HENDERSON JOHN T

Director

$276.15K (5)

$2.17M (6) scheduled

−$1.89M

78,090

0.0816%

$347.98K

+258.2%

GILBERT WALTER PHD

Director

$150.00K (1)

$1.44M (3) scheduled

−$1.29M

54,150

0.0566%

$241.30K

+333.2%

Reitan Colleen F

Director

—

$1.29M (1) scheduled

−$1.29M

152,030

0.1589%

$677.48K

—

Lambert Nicole

Chief Operating Officer

—

$1.13M (8)

−$1.13M

223,993

0.2342%

$998.16K

+752.6%

Phanstiel S. Louise

Director

$744.06K (4)

$1.68M (1) scheduled

−$933.68K

362,652

0.3791%

$1.62M

+26,160%

SPIEGELMAN DANIEL K

Director

—

$792.26K (6)

−$792.26K

32,917

0.0344%

$146.68K

—

Tobin Bernard

President Crescendo BioScience

—

$468.48K (1)

−$468.48K

160,636

0.1679%

$715.83K

+28.4%

Ford Alexander

Chief Operating Officer

—

$352.72K (3)

−$352.72K

169,040

0.1767%

$753.28K

+394.9%

Ancona Margaret

EVP, Strategy & Transformation

—

$320.99K (1)

−$320.99K

127,726

0.1335%

$569.17K

—

Parkinson Paul

Fmr EVP Strategy & Innovation

—

$295.60K (1)

−$295.60K

87,407

0.0914%

$389.50K

+13.8%

Kumar Rashmi

Director

—

$276.92K (2) scheduled

−$276.92K

171,889

0.1797%

$765.97K

—

Dreismann Heinrich

Director

—

$270.52K (1)

−$270.52K

231,145

0.2417%

$1.03M

+176.7%

DREISMANN HEINRICH

Director

—

$201.00K (1)

−$201.00K

83,527

0.0873%

$372.21K

+377.3%

Raha Samraat S.

President and CEO

$199.84K (1)

—

+$199.84K

1,068,083

1.12%

$4.76M

—

Newcomer Lee Nisley

Director

—

$156.86K (1)

−$156.86K

191,842

0.2006%

$854.89K

—

McDade Ralph L

President Myriad RBM, Inc.

—

$61.23K (1)

−$61.23K

142,095

0.1486%

$633.20K

+63.5%

Muzzey Dale

Chief Scientific Officer

—

$54.96K (1)

−$54.96K

326,310

0.3412%

$1.45M

+798.9%

Bisaro Paul

Director

$27.64K (1)

—

+$27.64K

157,142

0.1643%

$700.26K

—

Verratti Mark

Chief Operating Officer

—

629,646

0.6583%

$2.81M

+6,196%

Donnelly Brian J

Chief Commercial Officer

—

573,363

0.5994%

$2.56M

—

Sikri Vishal

EVP, Commercial

—

351,224

0.3672%

$1.57M

+275.7%

Fox Jennifer Lynne

Chief Legal Officer

—

305,964

0.3199%

$1.36M

—

Wheeler Benjamin Richard

Chief Financial Officer

—

289,748

0.3029%

$1.29M

+722.9%

Solaiman Shereen

Chief People Officer

—

267,801

0.2800%

$1.19M

—

Jampa Raj

Chief Technology Officer

—

251,889

0.2633%

$1.12M

—

Leffler Scott J.

Chief Financial Officer

—

218,393

0.2283%

$973.20K

+26,862%

Skovronsky Daniel

Director

—

195,507

0.2044%

$871.22K

—

Haas Kevin Richard

Chief Technology Officer

—

180,022

0.1882%

$802.21K

+454.9%

Jackson Benjamin

Former E.V.P., General Counsel

—

107,029

0.1119%

$476.94K

+506.4%

Davis Mark Steven

Director

—

106,665

0.1115%

$475.32K

—

Wong Pamela

Chief Legal Officer

—

65,002

0.0680%

$289.66K

—

BEST LAWRENCE C

Director

—

60,790

0.0636%

$270.89K

+247.4%

Santa Eric

Former Chief Growth Officer

—

56,734

0.0593%

$252.82K

—

Wenstrup Richard

Chief Medical Officer

—

50,207

0.0525%

$223.73K

−1.8%

Munk Natalie

Chief Accounting Officer

—

45,167

0.0472%

$201.27K

+77.8%

Sanders Walter Lloyd

President Myriad Oncology

—

36,195

0.0378%

$161.29K

−9.4%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Muzzey Dale

11 Sep 2024

Chief Scientific Officer

Sell

2,100

$26.17

$54.96K

Dreismann Heinrich

9 Sep 2024

Director

Sell

10,000

$27.05

$270.52K

Ancona Margaret

21 Aug 2024

SVP, Chief of Staff

Sell

11,538

$27.82

$320.99K

DIAZ PAUL J

15 May 2024

President and CEO

Sell

75,000

$25.07

$1.88M

DIAZ PAUL J

14 May 2024

President and CEO

Sell

95,000

$25.21

$2.39M

Newcomer Lee Nisley

13 May 2024

Director

Sell

6,200

$25.30

$156.86K

DIAZ PAUL J

13 May 2024

President and CEO

Sell

57,844

$25.13

$1.45M

SPIEGELMAN DANIEL K

2 Jun 2023

Director

Sell

8,638

$23.01

$198.76K

Lambert Nicole

27 Mar 2023

Chief Operating Officer

Sell

6,433

$23.48

$151.05K

Lambert Nicole

2 Mar 2023

Chief Operating Officer

Sell

13,184

$22.74

$299.82K

Riggsbee Richard Bryan

2 Mar 2023

Chief Financial Officer

Sell

15,000

$22.55

$338.25K

Riggsbee Richard Bryan

20 Jan 2023

Chief Financial Officer

Sell

9,400

$20.04

$188.39K

Riggsbee Richard Bryan

18 Jan 2023

Chief Financial Officer

Sell

600

$20.01

$12.01K

Riggsbee Richard Bryan

27 Dec 2022

Chief Financial Officer

Sell

20,000

$15.15

$302.99K

SPIEGELMAN DANIEL K

6 Jun 2022

Director

Sell

6,424

$19.25

$123.67K

Lambert Nicole

1 Oct 2021

See Remarks

Sell

1,420

$31.57

$44.83K

Lambert Nicole

27 Sep 2021

See Remarks

Sell

10,112

$33.10

$334.75K

LANCHBURY JERRY S

23 Sep 2021

Chief Scientific Officer

Sell

200

$35.06

$7.01K

Lambert Nicole

27 Aug 2021

See Remarks

Sell

945

$34.50

$32.60K

Riggsbee Richard Bryan

3 Aug 2021

Chief Financial Officer

Sell

14,983

$35.14

$526.48K

SPIEGELMAN DANIEL K

17 Jun 2021

Director

Sell

3,139

$30.52

$95.79K

SPIEGELMAN DANIEL K

28 May 2021

Director

Sell

7,142

$28.99

$207.02K

Lambert Nicole

19 Apr 2021

See Remarks

Sell

5,890

$27.01

$159.09K

Lambert Nicole

19 Apr 2021

See Remarks

Sell

759

$27.01

$20.50K

Parkinson Paul

8 Jan 2021

EVP Strategy and Innovation

Sell

11,824

$25.00

$295.60K

Ford Alexander

15 Sep 2020

Chief Operating Officer

Sell

2,804

$13.78

$38.63K

Lambert Nicole

12 Feb 2020

President, MGL

Sell

4,354

$19.73

$85.91K

Ford Alexander

5 Feb 2020

President, MWH

Sell

7,273

$30.00

$218.19K

Riggsbee Richard Bryan

1 Aug 2019

Chief Financial Officer

Sell

25,000

$41.50

$1.04M

Tobin Bernard

1 Aug 2019

President Crescendo BioScience

Sell

11,712

$40.00

$468.48K

McDade Ralph L

12 Mar 2019

President Myriad RBM, Inc.

Sell

1,975

$31.00

$61.23K

MARSH RICHARD M

12 Jan 2018

E.V.P., General Counsel

Sell

13,759

$36.25

$498.76K

GILBERT WALTER PHD

14 Dec 2017

Director

Sell

7,500

$33.19

$248.93K

DREISMANN HEINRICH

11 Dec 2017

Director

Sell

6,000

$33.50

$201.00K

Ford Alexander

13 Nov 2017

President, MGL

Sell

3,031

$31.64

$95.90K

Show all 135 transactions →

By person

Individual transactions

What was left out